Literature DB >> 7719913

Prevalence of antibodies against Borrelia species in patients with unclassified uveitis in regions in which Lyme disease is endemic and nonendemic.

K Kimura1, E Isogai, H Isogai, T Nishikawa, T Masuzawa, K Yoshikawa, S Kotake, S Ohno, N Fujii.   

Abstract

We studied 93 patients with unclassified uveitis from two regions in Japan (Hokkaido and Kanagawa) to assess the contribution of Borrelia species to this condition. The seroprevalence of antibody to Borrelia species was higher in patients from Hokkaido than in those from Kanagawa. The unclassified uveitis of seropositive patients was probably a complication of Lyme borreliosis since (i) the antibody titers were as high as those in clinically diagnosed Lyme disease patients, (ii) healthy controls from Hokkaido showed low seroprevalence in contrast with unclassified uveitis patients from Hokkaido, and (iii) the reaction pattern of antibodies in sera from patients with unclassified uveitis was the same as that in patients with Lyme disease. This is the first report to reveal the high risk of Lyme borreliosis in patients with unclassified uveitis in regions endemic for Lyme disease. In case of unclassified uveitis as well as in cases of inflammatory disease of unknown origin, Lyme disease should be taken into consideration, especially in regions in which Lyme diseases is endemic, even if it is reported only in animals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719913      PMCID: PMC170100          DOI: 10.1128/cdli.2.1.53-56.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  18 in total

1.  Prevalence of Lyme disease among patients with uveitis.

Authors:  J T Rosenbaum; D W Rahn
Journal:  Am J Ophthalmol       Date:  1991-10-15       Impact factor: 5.258

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Antibodies to Borrelia burgdorferi in dogs in Hokkaido.

Authors:  E Isogai; H Isogai; N Sato; M Yuzawa; M Kawakami
Journal:  Microbiol Immunol       Date:  1990       Impact factor: 1.955

4.  Evidence for (lipo) oligosaccharides in Borrelia burgdorferi and their serological specificity.

Authors:  M Cinco; E Banfi; D Balanzin; C Godeas; E Panfili
Journal:  FEMS Microbiol Immunol       Date:  1991-02

5.  Detection of antibodies against Borrelia burgdorferi in patients with uveitis.

Authors:  E Isogai; H Isogai; S Kotake; K Yoshikawa; A Ichiishi; S Kosaka; N Sato; S Hayashi; K Oguma; S Ohno
Journal:  Am J Ophthalmol       Date:  1991-07-15       Impact factor: 5.258

6.  Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6.

Authors:  G S Habicht; L I Katona; J L Benach
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

7.  Antigenic properties of Borrelia burgdorferi isolated from Ixodes ovatus and Ixodes persulcatus in Hokkaido, Japan.

Authors:  T Masuzawa; Y Okada; Y Yanagihara; N Sato
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

8.  Serological survey for Lyme disease in sika deer (Cervus nippon yesoensis) by enzyme-linked immunosorbent assay (ELISA).

Authors:  E Isogai; H Isogai; T Masuzawa; Y Yanagihara; N Sato; S Hayashi; T Maki; M Mori
Journal:  Microbiol Immunol       Date:  1991       Impact factor: 1.955

9.  Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct.

Authors:  J D Radolf; M V Norgard; M E Brandt; R D Isaacs; P A Thompson; B Beutler
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

10.  Canine Lyme disease: clinical and serological evaluations in 21 dogs in Japan.

Authors:  Y Azuma; E Isogai; H Isogai; K Kawamura
Journal:  Vet Rec       Date:  1994-04-09       Impact factor: 2.695

View more
  1 in total

1.  Detection of antibodies to Borrelia species among patients with confirmed sarcoidosis in a region where Lyme disease is nonendemic.

Authors:  M Ishihara; T Ishida; E Isogai; K Kimura; M Oritsu; Y Matsui; H Isogai; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-12       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.